Brinter Highlighted as One of the 3D Bioprinting Companies for Tissue and Organ Transplants on Nanalyze

2021-07-27T02:22:05-07:00July 27th, 2021|Business|

The media and research firm Nanalyze has highlighted Brinter as one of the eight 3D Bioprinting Companies for Medical Solutions in their article published on June 17, 2021. Nanalyze commented [...]

Brinter Raises €1.2M in Seed Funding to Accelerate 3D Printing Bioscience Research and Manufacturing for Uses That Range from Personalized Drugs to Human Spare Parts

2021-06-11T07:54:07-07:00June 11th, 2021|Business, Featured|

Turku, Finland (June 10th, 2021) Brinter announces the successful closure of a €1.2M seed funding round led by early-stage VC Innovestor. The company will use the capital to further [...]

Go to Top